United States · FDA National Drug Code directory
Bupropion Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 47335-954_5054c941-5817-4666-b562-800de8be86b2
- Product NDC
- 47335-954
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Bupropion Hydrochloride
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20141225
- Source listing expiry
- 20261231
Source-listed ingredients
- BUPROPION HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-954-13) · 47335-954-13
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-954-81) · 47335-954-81
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-954-83) · 47335-954-83
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →